MSE
GHDX

MUFG Securities EMEA’s Genomic Health, Inc. GHDX Stock Holding History

MUFG Securities EMEA’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-32,000
Closed -$2.25M – 771
2018
Q3 		$2.25M Buy
+32,000
New +$1.87M 0.03% 228

Other funds holding GHDX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

MUFG Securities EMEA's GHDX Position: Q4 2018 in Review

MUFG Securities EMEA sold out of Genomic Health, Inc. (GHDX) in Q4 2018, closing a stake of 32,000 shares — an estimated $2.25M sold.

MUFG Securities EMEA first reported a position in GHDX in Q3 2018 and held it in 1 quarter. The position peaked at $2.25M in Q3 2018. 228 funds tracked by Wall St. Rank hold GHDX as of Q4 2018.

  • MUFG Securities EMEA reported no remaining Genomic Health, Inc. position as of Q4 2018 after selling out during the quarter.
  • MUFG Securities EMEA sold 32,000 Genomic Health, Inc. shares in Q4 2018, an estimated $2.25M.
  • MUFG Securities EMEA first reported a position in Genomic Health, Inc. in Q3 2018 and held it in 1 quarter.
  • MUFG Securities EMEA's Genomic Health, Inc. position peaked at $2.25M in Q3 2018.
  • 228 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2018.

Based on MUFG Securities EMEA's 13F filing for Q4 2018, filed 14 Feb 2019.